This Belfast-based medtech firm works with 31 of the top 35 pharmaceutical companies in the world and has relationships with 1,200 laboratories globally. It helps pharmaceutical companies to launch their diagnostic tests by assisting them to understand the diagnostic market, build a diagnostic plan and then implement it. The business was founded in 2005 by chief executive Peter Keeling, 58, and sales reached £7.4m last year. In April it raised $5m from WhiteRock Capital Partners and Silicon Valley Bank to support its global expansion plans.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.